Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000008653
JPRN-UMIN000008653
Completed
未知

A clinical trial to establish the proper diagnosis and therapy of Hypereosinophilic syndrome. - Efficacy of Imatinib for HES

Kobe University Medical School Hospital0 sites30 target enrollmentAugust 15, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHypereosinophilic syndrome, chronic eosinophilic leukemia

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypereosinophilic syndrome, chronic eosinophilic leukemia
Sponsor
Kobe University Medical School Hospital
Enrollment
30
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 15, 2012
End Date
September 30, 2016
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kobe University Medical School Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\) Presence of any other active neoplasm 2\) Prior anti\-leukemic treatment within two weeks. 3\) Psychological disorder 4\) Hypersensitivity to ingredient of Imatinib 5\) Pregnant or nursing women 3\) Whom the investigator considered inappropriate to this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A clinical study to establish in diagnostic criteria and treatment guideline of relapsing polychondritis.Relapsing polychondritis
JPRN-UMIN000003869St. Marianna University School of Medicine30
Recruiting
Not Applicable
A clinical trial designed to verify the effectiveness of a low-level medical laser apparatus TINI” in improving tinnitus symptoms of chronic high-frequency tinnitus patientsDiseases of the ear and mastoid process
KCT0006636WONTECH56
Active, not recruiting
Phase 1
Paediatric brain tumoursIntracranial Germ Cell tumours of any histology and intracranial site and disseminationMedDRA version: 20.0Level: LLTClassification code 10065853Term: Nongerminomatous germ cell tumor of the CNSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10018207Term: GerminomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2009-018072-33-BEniversitätsklinikum Münster400
Active, not recruiting
Phase 1
Paediatric brain tumoursIntracranial Germ Cell tumours of any histology and intracranial site and disseminationMedDRA version: 20.0Level: LLTClassification code 10065853Term: Nongerminomatous germ cell tumor of the CNSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10018207Term: GerminomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2009-018072-33-ATniversitätsklinikum Münster394
Active, not recruiting
Phase 1
Paediatric brain tumoursIntracranial Germ Cell tumours of any histology and intracranial site and disseminationMedDRA version: 20.0Level: LLTClassification code 10065853Term: Nongerminomatous germ cell tumor of the CNSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10018207Term: GerminomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2009-018072-33-DEniversitätsklinikum Münster400